EU PERSPECTIVES - The WHO will soon open its first global rare disease plan for public comment, with patient groups expecting just 30 days to respond. They want Europe's 18-priority blueprint to help mould it. Read more
An editorial studio for health and life sciences in Europe
Founded and run by Nicole Verbeeck, an independent journalist covering health and life sciences. Juneau Cayenne publishes nexxahealth, and takes on journalism, editorial work and creative editorial formats.
nexxahealth
Europe's health & life sciences magazine
Europe's health & life sciences magazine launching on 12 October 2026. Four issues a year, in print. For innovators, health systems, policymakers, healthcare professionals, investors, patient organisations, and more.
Issue 01 - Counting on Europe - Autumn 2026 now available!
What the studio does
Journalism
Reporting on health and life sciences in Europe for Rapporteur (Euractiv), EU Perspectives, European Biotechnology Magazine and APM Market Access.
Editorial work
Commissioned writing and editing for organisations in health and life sciences. Interviews, features, reports, and the editing that makes them shine.
Creative editorial formats
Some subjects do not fit an article. The studio designs the format as well as the words, a series, a publication, a report built to be kept rather than filed.
Latest reporting
okt 24
European heart device will reach US patients first. EU is failing to fund innovation, its CEO says
EU PERSPECTIVES - A European company is developing a device that could help doctors better manage heart failure. Yet, US patients will get it first. Its CEO says in an interview that the EU's reimbursement system is to blame. Read more
EU PERSPECTIVES - Investors want evidence before they back new tests, but without investment, the data needed to prove their value may never materialise. Berlin startup theblood hopes menstrual blood could help close that gap in conditions such as endometriosis, although EU rules for diagnostic tests do not yet explicitly recognise the sample. Read...
NEXXAHEALTH - For years, Europe's low medicine prices and its patchwork of national markets were things it could live with. America's new pricing rules has turned both against it. Bas Amesz, who a decade ago proposed a different way to pay for medicines, argues the shock is Europe's chance to buy innovation as a single bloc, and...
